Literature DB >> 12696999

Repetitive transcranial magnetic stimulation : does it have potential in the treatment of depression?

Frank Padberg1, Hans-Jürgen Möller.   

Abstract

Transcranial magnetic stimulation (TMS) has become a major research tool in experimental clinical neurophysiology as a result of its potential to noninvasively and focally stimulate cortical brain regions. Currently, studies are being conducted to investigate whether repetitive TMS (rTMS)-mediated modulation of cortical function may also provide a therapeutic approach in neurological and psychiatric disorders. Preclinical findings have shown that prefrontal rTMS can modulate the function of fronto-limbic circuits, which is reversibly altered in major depression. rTMS has also been found to exert effects on neurotransmitter systems involved in the pathophysiology of major depression (e.g. stimulates subcortical dopamine release and acts on the hypothalamic pituitary adrenal axis, which is dysregulated in depression). To date, numerous open and controlled clinical trials with widely differing stimulation parameters have explored the antidepressant potential of rTMS. Though conducted with small sample sizes, the majority of the controlled trials demonstrated significant antidepressant effects of active rTMS compared with a sham condition. Effect sizes, however, varied from modest to substantial, and the patient selection focused on therapy-resistant cases. Moreover, the average treatment duration was approximately 2 weeks, which is short compared with other antidepressant interventions. Larger multicentre trials, which would be mandatory to demonstrate the antidepressant effectiveness of rTMS, have not been conducted to date.A putative future application of rTMS may be the treatment of patients who did not tolerate or did not respond to antidepressant pharmacotherapy before trying more invasive strategies such as electroconvulsive therapy and vagus nerve stimulation. Theoretically, rTMS may be also applied early in the course of disease in order to speed up and increase the effects of antidepressant pharmacotherapy. However, this application has not been a focus of clinical trials to date. Research efforts should be intensified to further investigate the effectiveness of rTMS as an antidepressant intervention and to test specific applications of the technique in the treatment of depressive episodes.

Entities:  

Mesh:

Year:  2003        PMID: 12696999     DOI: 10.2165/00023210-200317060-00002

Source DB:  PubMed          Journal:  CNS Drugs        ISSN: 1172-7047            Impact factor:   5.749


  133 in total

1.  Double-blind controlled investigation of transcranial magnetic stimulation for the treatment of resistant major depression.

Authors:  C Loo; P Mitchell; P Sachdev; B McDarmont; G Parker; S Gandevia
Journal:  Am J Psychiatry       Date:  1999-06       Impact factor: 18.112

2.  How coil-cortex distance relates to age, motor threshold, and antidepressant response to repetitive transcranial magnetic stimulation.

Authors:  F A Kozel; Z Nahas; C deBrux; M Molloy; J P Lorberbaum; D Bohning; S C Risch; M S George
Journal:  J Neuropsychiatry Clin Neurosci       Date:  2000       Impact factor: 2.198

Review 3.  Repetitive transcranial magnetic stimulation as a neuropsychiatric tool: present status and future potential.

Authors:  R M Post; T A Kimbrell; U D McCann; R T Dunn; E A Osuch; A M Speer; S R Weiss
Journal:  J ECT       Date:  1999-03       Impact factor: 3.635

4.  Transcranial magnetic stimulation during positron emission tomography: a new method for studying connectivity of the human cerebral cortex.

Authors:  T Paus; R Jech; C J Thompson; R Comeau; T Peters; A C Evans
Journal:  J Neurosci       Date:  1997-05-01       Impact factor: 6.167

5.  Methodological aspects in the assessment of severity of depression by the Hamilton Depression Scale.

Authors:  H J Möller
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  2001       Impact factor: 5.270

6.  Repetitive transcranial magnetic stimulation (rTMS) in pharmacotherapy-refractory major depression: comparative study of fast, slow and sham rTMS.

Authors:  F Padberg; P Zwanzger; H Thoma; N Kathmann; C Haag; B D Greenberg; H Hampel; H J Möller
Journal:  Psychiatry Res       Date:  1999-11-29       Impact factor: 3.222

7.  Effects of left frontal transcranial magnetic stimulation on depressed mood, cognition, and corticomotor threshold.

Authors:  W J Triggs; K J McCoy; R Greer; F Rossi; D Bowers; S Kortenkamp; S E Nadeau; K M Heilman; W K Goodman
Journal:  Biol Psychiatry       Date:  1999-06-01       Impact factor: 13.382

8.  Lack of adverse cognitive effects of 1 Hz and 20 Hz repetitive transcranial magnetic stimulation at 100% of motor threshold over left prefrontal cortex in depression.

Authors:  A M Speer; J D Repella; S Figueras; N K Demian; T A Kimbrell; E M Wasserman; R M Post
Journal:  J ECT       Date:  2001-12       Impact factor: 3.635

9.  Long-term repetitive transcranial magnetic stimulation increases the expression of brain-derived neurotrophic factor and cholecystokinin mRNA, but not neuropeptide tyrosine mRNA in specific areas of rat brain.

Authors:  M B Müller; N Toschi; A E Kresse; A Post; M E Keck
Journal:  Neuropsychopharmacology       Date:  2000-08       Impact factor: 7.853

10.  A controlled trial of daily left prefrontal cortex TMS for treating depression.

Authors:  M S George; Z Nahas; M Molloy; A M Speer; N C Oliver; X B Li; G W Arana; S C Risch; J C Ballenger
Journal:  Biol Psychiatry       Date:  2000-11-15       Impact factor: 13.382

View more
  4 in total

Review 1.  Clinical trial design in non-invasive brain stimulation psychiatric research.

Authors:  André Russowsky Brunoni; Felipe Fregni
Journal:  Int J Methods Psychiatr Res       Date:  2011-06       Impact factor: 4.035

Review 2.  Repetitive transcranial magnetic stimulation (rTMS) for the treatment of depression in Parkinson disease: a meta-analysis of randomized controlled clinical trials.

Authors:  Cheng-Long Xie; Jie Chen; Xiao-Dan Wang; Jia-Lin Pan; Yi Zhou; Shi-Yi Lin; Xiao-Dong Xue; Wen-Wen Wang
Journal:  Neurol Sci       Date:  2015-07-26       Impact factor: 3.307

3.  Low-Dimensional Models of "Neuro-Glio-Vascular Unit" for Describing Neural Dynamics under Normal and Energy-Starved Conditions.

Authors:  Karishma Chhabria; V Srinivasa Chakravarthy
Journal:  Front Neurol       Date:  2016-03-09       Impact factor: 4.003

4.  Left Dorsolateral Prefrontal Cortex Glx/tCr Predicts Efficacy of High Frequency 4- to 6-Week rTMS Treatment and Is Associated With Symptom Improvement in Adults With Major Depressive Disorder: Findings From a Pilot Study.

Authors:  Pallab Bhattacharyya; Amit Anand; Jian Lin; Murat Altinay
Journal:  Front Psychiatry       Date:  2021-12-03       Impact factor: 4.157

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.